Haas, J., Schneider, K., Schwarz, A., Korporal-Kuhnke, M., Faller, S., Jarius, S., & Wildemann, B. (2017). Th17 cells: A prognostic marker for MS rebound after natalizumab cessation? Multiple sclerosis journal, 23(1), . https://doi.org/10.1177/1352458516640609
Chicago-Zitierstil (17. Ausg.)Haas, Jürgen, Katharina Schneider, Alexander Schwarz, Mirjam Korporal-Kuhnke, Simon Faller, Sven Jarius, und Brigitte Wildemann. "Th17 Cells: A Prognostic Marker for MS Rebound After Natalizumab Cessation?" Multiple Sclerosis Journal 23, no. 1 (2017). https://doi.org/10.1177/1352458516640609.
MLA-Zitierstil (9. Ausg.)Haas, Jürgen, et al. "Th17 Cells: A Prognostic Marker for MS Rebound After Natalizumab Cessation?" Multiple Sclerosis Journal, vol. 23, no. 1, 2017, https://doi.org/10.1177/1352458516640609.